An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

NCT00412620 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
156
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott